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INTRODUCTION
Pregnancy requires the establishment of selective immuno-
logic tolerance to allow implantation and growth of the fetus.
Recent investigations have suggested that, during pregnan-
cy, maternal circulating immune cells undergo important
changes that result in alterations in their cell counts, pheno-
types, functions and ability to produce soluble factors (1).
During this physiological state, immune regulation involves
a shift from T-helper 1 (Th1) to T-helper 2 (Th2) activity (2-
4). It has been also observed that neonates are deficient in the
Th1 response and that cord blood transplantation results in
less graft-versus-host disease (GvHD) (5-7).
The dendritic cell (DC), an important antigen-presenting
cell, plays a key role in adaptive immune responses. Depend-
ing on their developmental origin, cytokine activators, sur-
face antigens and functional capacity, dendritic cells can be
subdivided into two major distinct populations, referred to
as myeloid and lymphoid DC (8). Myeloid DC are CD11c
+/
CD123±, and induce Th1 cell differentiation, whereas lym-
phoid DC are CD11c-/CD123
+++ and induce Th2 cell dif-
ferentiation (8, 9). A recently reported third population of
dendritic cells, referred to as CD11c-/CD123±, is thought
to be a less differentiated DC population (10-12). Although
a number of studies have tried to correlate the changes in
immune status during pregnancy or in neonates with changes
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Differences in Circulating Dendritic Cell Subtypes in Pregnant
Women, Cord Blood and Healthy Adult Women
Different subtypes of dendritic cells (DC) influence the differentiation of naive T lym-
phocytes into T helper type 1 (Th1) and Th2 effector cells. We evaluated the per-
centages of DC subtypes in peripheral blood from pregnant women (maternal blood)
and their cord blood compared to the peripheral blood of healthy non pregnant wo-
men (control). Circulating DC were identified by flow cytometry as lineage (CD3,
CD14, CD16, CD19, CD20, and CD56)-negative and HLA-DR-positive cells. Sub-
types of DC were further characterized as myeloid DC (CD11c+/CD123
±), lymphoid
DC (CD11c-/CD123+++) and less differentiated DC (CD11c-/CD123
±). The frequen-
cy of DC out of all nucleated cells was significantly lower in maternal blood than in
control (P<0.001). The ratio of myeloid DC/lymphoid DC was significantly higher in
maternal blood than in control (P<0.01). HLA-DR expressions of myeloid DC as
mean fluorescence intensity (MFI) were significantly less in maternal blood and in
cord blood than in control (P<0.001, respectively). The DC differentiation factors,
TNF-αand GM-CSF, released from mononuclear cells after lipopolysaccharide
stimulation were significantly lower in maternal blood than in control (P<0.01). The
distribution of DC subtypes was different in maternal and cord blood from those of
non-pregnant women. Their role during pregnancy remains to be determined.
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′in DC subtype populations in the peripheral blood of preg-
nant women or in their cord blood, the results have been in-
consistent (12-19) and there is no available data in Korean
population.
In this study, in order to minimize the in vitro effect of cell-
preparation, we employed a direct immunofluorescence tech-
nique on whole blood samples and four-color flow cytome-
try (19, 20) to evaluate the proportion of each DC subtype
in the peripheral blood of pregnant women at the time of
delivery, in their umbilical cord blood, and in the peripheral
blood of age-matched healthy, non-pregnant women in Kore-
an population. 
MATERIALS AND METHODS
Study populations
Thirty pregnant women with uncomplicated labor were
enrolled in the study. They provided written informed con-
sent before being admitted for delivery at the Gynaecology-
Obstetrics Department of Seoul National University Bora-
mae Hospital. Cord blood was collected in plastic bags con-
taining citrate phosphate dextrose adenine (CPDA) solution
before placental delivery. Maternal peripheral blood was col-
lected in tubes containing CPDA solution (Becton Dickin-
son, Franklin Lakes, NJ, U.S.A.) at the time of delivery. Twen-
ty nine age-matched healthy, non-pregnant volunteer women
were used as a control group. Complete blood counts were
obtained for all the collected samples considering the ratio
of CPDA solution to collected blood. The study design was
accepted by the Institutional Review Board of Seoul Nation-
al University Boramae Hospital.
Immunophenotyping
The subtypes of dendritic cells from whole blood samples
were analyzed as previously described (19, 20). A total of 50
μ L of whole blood was incubated with optimum amounts (as
indicated in the instructions of the manufacturer) of mouse
anti-human CD123-PE, CD11c-APC, HLA-DR-PerCP and
a lineage cocktail 1-fluorescein isothiocyanate (Lin1-FITC)
(containing a mixture of FITC-conjugated anti-CD3, anti-
CD14, anti-CD16, anti-CD19, anti-CD20 and anti-CD56
antibodies) (BD Biosciences, San Jose, CA, U.S.A.) for 25 min
at room temperature in the dark. Mouse anti-human IgG iso-
type control for each monoclonal antibody was used to deter-
mine background fluorescence levels. After the incubation
period, 2 mL of FACS lysing solution (BD Biosciences) dilut-
ed 1:10 in distilled water was added and the samples were
incubated under the same conditions for another 15 min to
fix leukocytes and to lyse nonnucleated red cells. Cells were
washed twice with phosphate-buffered saline (PBS), and then
resuspended in 0.5 mL of PBS.
Labeled cells were analyzed with a FACSAria flowcytome-
ter (Becton Dickinson) using FACSDivaTM Software (Becton
Dickinson). From each sample, 100,000 events were acquired
and analyzed. A gate on mononuclear cells was established and
drawn (Fig. 1; P1 gate). Dendritic cells are negative for lin-
eage cocktail but express HLA-DR (Fig. 1; P2 gate). Among
the DC population, cells expressing CD11c were character-
ized as myeloid DC: CD11c
+/CD123± (P3 gate), whereas
cells expressing CD123 with high intensity were character-
ized as lymphoid DC: CD11c-/CD123
+++ (P5 gate). Cells ex-
pressing CD123 with low intensity were characterized as less
differentiated DC: CD11c-/CD123± (P4 gate), as previous-
ly described (12, 19). Results were expressed as a percentage
of total DC to ANC (all nucleated cells) and PBMC (periph-
eral blood mononuclear cells). Absolute numbers of DC were
calculated from complete and differential blood cell counts.
Subpopulations of myeloid DC, lymphoid DC, and less dif-
ferentiated DC were expressed as percentages of total DC. The
intensity of HLA-DR expression by each DC subtype was
estimated from the mean fluorescence intensity (MFI).
Measurement of cytokine release
Mononuclear cells (MNC) from cord blood and peripher-
al blood of pregnant (n=6) and non-pregnant women (n=6)
were obtained by Ficoll-Hypaque (Amersham Biosciences,
Uppsala, Sweden) density gradient centrifugation. MNC (2.5
×106 cells/mL) were cultured with RPMI 1640 (Gibco BRL,
Life Technologies, Paisley, U.K.) containing 10% heat-inac-
tivated fetal calf serum in 96-well plate in the presence of
lipopolysaccharide (LPS) (Sigma Aldrich, St. Louis, MO, U.
S.A.) for 16 hr at 37℃, and supernatants were taken for cy-
tokine measurement. Procarta Cytokine Multiplex Assay kit
(Panomics, Fremont, CA, U.S.A.) analyzed with Bio-Plex
Assay System (Bio-Rad, Hercules, CA, U.S.A.) was used to
measure IL-1β , IL-6, IL-10, TNF-αand GM-CSF.
Statistical analysis
Results are expressed as the mean±standard deviation
(SD). Differences in frequency of dendritic cells and the MFI
of HLA-DR between healthy, non-pregnant women (control)
and pregnant women (maternal blood) or cord blood were
tested by Student’s t test. Those between maternal and cord
blood were tested by Student’s t test for paired samples. Dif-
ferences of cytokine release between control and maternal
blood or cord blood were analyzed by Mann-Whitney U test,
and those between maternal and cord blood were analyzed
by Wilcoxon signed rank test. The correlations of the char-
acteristics between maternal blood and their paired cord blood
were evaluated using the Spearman R test. The statistical anal-
ysis was performed with SPSS V 12.0 (SPSS Inc., Chicago,
IL, U.S.A.) and all comparisons and correlations were consid-
ered significant if the Pvalue was less than 0.05.
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Comparison of the dendritic cell subtypes of pregnant
and non-pregnant women
The frequency of dendritic cells (linage-/HLA-DR
+) in all
nucleated cells was markedly decreased in the peripheral blood
of pregnant women (maternal blood) compared to healthy,
non-pregnant women (control) (0.34±0.21% vs. 1.15±
0.31%, P<0.001) (Table 1). The percentage of lymphoid DC
was lower in maternal blood than in the control (42.6±13.6%
vs. 58.9±11.8%, P<0.001) (Fig. 2A) and the myeloid DC/
lymphoid DC ratio was higher in maternal blood than in that
of control (0.75±0.53 vs. 0.44 ±0.26, P<0.01) (Fig. 3). The
percentage of less differentiated DC was also higher in mater-
nal blood than in the control (30.7±13.0% vs. 17.5±8.8%,
P<0.001) (Fig. 2A). The MFI of HLA-DR on the myeloid DC
was significantly lower in maternal blood than in the control
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Fig. 1. Identification of circulating dendritic cells (DC) by flow cytometry. (A) The mononuclear cell analysis gate was applied to light scat-
ters (P1). (B) The gated events were analyzed for lineage cocktail (a mixture of FITC-conjugated anti-CD3, anti-CD14, anti-CD16, anti-CD19,
anti-CD20 and anti-CD56 antibodies) and HLA-DR. P2 gate represented total DC (lineage-/HLA-DR
+). (C) The P2-gated events were ana-
lyzed for CD123 and CD11c staining. Myeloid DC (lineage-/HLA-DR
+/CD11c
+/CD123
±) were represented in gate P3, lymphoid DC (lin-
eage-/HLA-DR
+/CD11c-/CD123
+++) in gate P5, and less differentiated DC (lineage-/HLA-DR
+/CD11c-/CD123
±) in gate P4. Healthy, non-
pregnant women (control), left panel; peripheral blood of pregnant women (maternal blood), middle panel; cord blood, right panel.
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A(16,605±4,004 vs. 23,435±5,007, P<0.001) (Fig. 2B).
TNF-α and GM-CSF secretion of mononuclear cells (MNC)
after LPS stimulation were significantly lower in maternal
blood than in the control (P<0.01, respectively) (Fig. 4). The
production of IL-1β , IL-6 and IL-10 of MNC from maternal
blood was not different from the control.
Comparison of the dendritic cell subtypes of cord blood
and the blood of non-pregnant women
The frequency of dendritic cells among all nucleated cells
was also significantly less in cord blood than in the control
(0.85±0.35% vs. 1.15±0.31%, P<0.001) (Table 1). The
percentages of myeloid DC and lymphoid DC in cord blood
were not different from the control (Fig. 2A), and the myeloid
DC/lymphoid DC ratio in cord blood was also not different
from the control (Fig. 3). The MFI of HLA-DR on myeloid
DC from cord blood was significantly less than in blood of
healthy, non-pregnant women (15,873±4,274 vs. 23,435
±5,007, P<0.001) (Fig. 2B). TNF-αand GM-CSF released
from MNC of cord blood after LPS stimulation showed a ten-
dency of decreasing in cord blood compared to control but
did not reach statistical significance (Fig. 4). The produc-
tion of IL-1β , IL-6 and IL-10 of MNC from cord blood was
not different from control.
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Results were expressed as mean±standard deviation. WBC, white
blood cells; DC, dendritic cells; ANC, all nucleated cells; PBMC, periph-
eral blood mononuclear cells; Differences between healthy, non-preg-
nant women (control) and pregnant women (maternal blood) or cord
blood were tested by Student’s t test. *P<0.01; 
� P<0.001. Differences
between maternal blood and cord blood were tested by Student’s t test
for paired samples. 
� P<0.001.
Control (n=29)
Pregnant women (n=30)
Maternal blood Cord blood
WBC count 6,253±1,166 8,996±2,690
� 11,886±3,570
�
% DC/ANC 1.15±0.31 0.34±0.21
� 0.85±0.35
� ,�
% DC/PBMC 2.07±0.70 1.31±0.53
� 2.10±0.81
�
DC/μ L of blood 72.6±24.1 29.9±24.7
� 102.8±53.7*,�
Table 1. Frequency of dendritic cells in peripheral blood of he-
althy, non-pregnant women (control) and pregnant women (ma-
ternal blood) and their cord blood
Fig. 2. (A) The percentage of myeloid dendritic cells (DC), lymphoid DC and less differentiated DC in peripheral blood of healthy, non-preg-
nant women (control), peripheral blood of pregnant women (maternal blood) and cord blood. (B) The expression of HLA-DR as mean flu-
orescence intensity (MFI) in subtypes of DC of each group. Error bars represent standard deviations. Differences between peripheral blood
of healthy, non-pregnant women (control) and pregnant women (maternal blood) and cord blood were tested by Student’s t t-test. Differ-
ences between peripheral blood of pregnant women (maternal blood) and cord blood were tested by Student’s test for paired samples.
*P<0.05; 
� P<0.01; 
� P<0.001.
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Fig. 3. The scatter plot shows ratio of myeloid dendrite cell (DC)/
lymphoid DC in peripheral blood of healthy, non-pregnant women
(control), peripheral blood of pregnant women (maternal blood)
and cord blood. Horizontal bars represent the mean ratio of myeloid
DC/lymphoid DC. Differences between peripheral blood of healthy,
non-pregnant women (control) and peripheral blood of pregnant
women (maternal blood) or cord blood were tested by Student’s t
test. Differences between peripheral blood of pregnant women
(maternal blood) and cord blood were tested by Student’s t test
for paired samples. *P<0.01.
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�Correlations of characteristics between maternal blood
and paired cord blood
Among all the characteristics tested on thirty maternal
blood and their paired cord blood samples, there were sig-
nificant correlations in total WBC count (r=0.378, P=0.04),
the frequency of dendritic cells among PBMC (r=0.449, P=
0.01), the absolute number of dendritic cells (r=0.407, P=
0.03) and MFI of lymphoid dendritic cells (r=0.753, P<
0.001) between maternal blood and their paired cord blood
(Table 2).
DISCUSSION
A significant decrease in the amount of DC in maternal
blood was observed in our study. It has been suggested that
during pregnancy, maternal dendritic cells take up apototic
placental syncytiotrophoblast debris, present fetal HLA class
II antigens to maternal T cells, and induce immunologic tol-
erance to the fetus (21). The hypothesis could partly explain
the marked decrease in the frequency of dendritic cells in ma-
ternal blood seen in our study.
The immunological features of pregnancy and of neonates
are known to be shifted to the Th2 response (2-5, 7). As dif-
ferent DC subtypes are known to play an important role in
eliciting Th1 and Th2 responses, considerable effort have
been made to identify differences in the DC subtypes of cord
blood and maternal blood. Despite this, however, the results
have been conflicting (12-19). This can be partly explained
by the use of different detection procedures and antibodies
(22, 23). An increase in the lymphoid DC population was
reported in cord blood by the negative selection method and
with anti-CD11c/CD123 antibodies (13, 14), but no signif-
icant difference was observed in whole blood samples with
the direct immunofluorescence technique using same anti-
CD11c/CD123 antibodies (12, 15, 18, 19). In our study,
though we also used whole blood samples with direct imm-
unofluorescence technique, the myeloid DC/lymphoid DC
ratio was significantly increased in maternal blood. Therefore,
the Th2 shift during pregnancy cannot be explained by the
increase in the proportion of lymphoid DC.
Although the myeloid DC and lymphoid DC subtypes
have been reported to primarily induce Th1 differentiation
and the Th2 response, respectively (8, 9), recent evidence
suggests that the opposite may also be true depending on
various factors, such as the maturational status, the cytokine
microenvironment, and the type of pathogen to which den-
dritic cells are exposed (24-26). In our study, although the
myeloid DC/lymphoid DC ratio was significantly higher in
maternal blood than non-pregnant women, HLA-DR expres-
sion level of dendritic cells and DC differentiation cytokines
(TNF-αand GM-CSF) production of MNC after LPS stim-
ulation were significantly lower in maternal blood than non-
pregnant women. The present data suggests that the Th2
dominant status seen in pregnant women and neonates is
more a consequence of the immature status of the dendritic
cells by the decrease of DC differentiation cytokines rather
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Fig. 4. The TNF-α (panel A) and GM-CSF (panel B) secretion of mononuclear cells with or without lipopolysaccharide (LPS, 20 ng/mL) stimu-
lation in peripheral blood of healthy, non-pregnant women (control), peripheral blood of pregnant women (maternal blood) and cord blood.
Error bars represent standard deviations. Differences between peripheral blood of healthy, non-pregnant women (control) and pregnant
women (maternal blood) and cord blood were tested by Mann-Whitney U test. Differences between maternal blood and cord blood were
tested by Wilcoxon signed rank test. *P<0.01
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*Only statistically significant correlations have been shown.
WBC, white blood cells; DC, dendritic cells; PBMC, peripheral blood
mononuclear cells; MFI, mean fluorescent intensity; lDC, lymphoid den-
dritic cells; Correlations between maternal blood and their paired cord
blood were evaluated by Spearman correlation coefficient (r) test.
Spearman r P value*
WBC count 0.378 0.04
% DC/PBMC 0.449 0.01
DC/μ L of blood  0.407 0.03
MFI of lDC 0.753 <0.001
Table 2. Correlations between maternal blood and paired cord
blood (n=30)
LPS (-)than the increased proportion of lymphoid DC.
It is also noteworthy that the less differentiated DC subtype
constituted a major fraction of the DC population in mater-
nal blood, which is in accordance with some previous reports
(12, 19). The existence of less differentiated DC, characterized
as CD11c-/CD123±/HLA-DR
+ cells in maternal or cord
blood, has recently been recognized, but their role in elicit-
ing immunological responses has not been elucidated yet (12,
19). In cancer patients, the frequency of the newly defined
HLA-DR+ immature cells (characterized as CD11c-/CD123-/
HLA-DR
+ cells showing a similar immunophenotype to the
less differentiated DC) is significantly increased, and these
cells show a reduced capacity to capture antigens, as well as
poor induction of the proliferation and IFN-γsecretion of
T-lymphocytes (27). The relevance of the less differentiated
dendritic cell subtype in maternal blood seems worthy of
further investigation.
In our study, many characteristics of cord blood were sim-
ilar to those of maternal blood however they did not reach
statistical significance. Similar features have been reported
(18, 19). Interestingly, there are significant correlations in
some characteristics such as the frequency of dendritic cells
among PBMC or MFI of lymphoid dendritic cells between
maternal blood and paired cord blood, which implies some
biological effects of maternal status on those of cord blood.
We also need further studies to elucidate it.
In summary, our study revealed that the myeloid DC/lym-
phoid DC ratio was not decreased in maternal or cord blood.
Instead, expression of HLA-DR on myeloid DC and DC dif-
ferentiation cytokines (TNF-αand GM-CSF) released from
MNC were decreased in maternal and cord blood, which im-
plicates that the maturation status of dendritic cells is more
of a critical factor in the regulation of immunologic tolerance
during pregnancy. Further studies are needed to clarify the
functional relevance of each subtype of dendritic cells in the
regulation of tolerogenic immune responses of pregnancy.
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